Cross-Validation of a New Procedure for Early Screening of Smoking Cessation Medications in Humans
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Brief procedures for evaluating medication efficacy may reveal which candidate drugs warrant further testing in clinical trials and which do not. We previously carried out a study of smoking abstinence, involving the nicotine patch, and established the sensitivity of our procedure. In this study, we sought to cross-validate our earlier work by comparing short-term smoking abstinence due to varenicline (relative to placebo) in smokers with high intrinsic quit interest (n = 57) and those with low intrinsic quit interest (n = 67). All the subjects were randomly assigned to either abstinence reinforcement ($12/day) or no reinforcement. In a crossover design, all the subjects participated in two 3-week phases: ad libitum smoking (week 1), dose run-up of varenicline (1.0 mg b.i.d.) or placebo (week 2), and quit attempt on medication verified daily by carbon monoxide <5 ppm (week 3). As with the nicotine patch in the previous study, varenicline (relative to placebo) increased abstinence more effectively in those with high intrinsic quit interest than in those with low quit interest but did not affect abstinence due to reinforcement. These data confirm the feasibility of a brief, sensitive test of the efficacy of cessation medications in smokers with high quit interest.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Cox, L. S., Tiffany, S. T., & Christen, A. G. (2001) · Nicotine & Tobacco Research · doi:10.1080/14622200020032051 · Cited by 1,188
Rollema, H., Chambers, L. K., Coe, J. W., Glowa, J., Hurst, R. S., Lebel, L. A., Lu, Y., Mansbach, R. S., Mather, R. J., Rovetti, C. C., et al. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.10.016 · Cited by 533
Symptoms of Tobacco Withdrawal: A Replication and Extension
Hughes, J. R. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810250054007 · Cited by 449
The State of Innovation in Drug Development
Kola, I. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100479 · Cited by 276 · cited 9×
“Yet the triple interaction of medication × medication order × quit interest was significant (F(1, 108) = 4.”
BackgroundInfluentialVarenicline improves mood and cognition during smoking abstinence
Patterson, F., Jepson, C., Strasser, A. A., Loughead, J., Perkins, K. A., Gur, R. C., Frey, J. M., Siegel, S., & Lerman, C. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.028 · Cited by 222
Self-citationWest, R., Baker, C. L., Cappelleri, J. C., & Bushmakin, A. G. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1041-3 · Cited by 203
Cited by
Incentives for smoking cessation
Cahill, K., Hartmann-Boyce, J., & Perera, R. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004307.pub5 · Cited by 324
Incentives for smoking cessation
Notley, C., Gentry, S., Livingstone-Banks, J., Bauld, L., Perera, R., & Hartmann-Boyce, J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004307.pub6 · Cited by 246
Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment
Ashare, R. L., Falcone, M., & Lerman, C. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.034 · Cited by 170
“Third, motivation to quit smoking may be an important factor in the sensitivity of paradigms for testing abstinence effects, particularly with respect to treatment effects on quitting smoking (Perkins et al., 2010, 2008).”
Self-citationAge‐related differences in working memory deficits during nicotine withdrawal
Falcone, M., Wileyto, E. P., Ruparel, K., Gerraty, R. T., LaPrate, L., Detre, J. A., Gur, R., Loughead, J., & Lerman, C. (2014) · Addiction Biology · doi:10.1111/adb.12051 · Cited by 48
Self-citation
Metadata
- Authors
- Perkins, K. A., Lerman, C., Fonte, C. A., Mercincavage, M., Stitzer, M. L., Chengappa, K. N. R., & Jain, A.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2010-05-19
- Volume
- 88
- Issue
- 1
- Pages
- 109-114
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2090843109
- Cited by
- 46
- References
- 9
- FWCI
- 3.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cross-Validation of a New Procedure for Early Screening of Smoking Cessation Medications in Humans. https://app.cochat.ai/papers/10.1038/clpt.2010.65
- The paper
- Perkins, K. A., Lerman, C., Fonte, C. A., Mercincavage, M., Stitzer, M. L., Chengappa, K. N. R., & Jain, A. (2010). Cross-Validation of a New Procedure for Early Screening of Smoking Cessation Medications in Humans. Clinical Pharmacology & Therapeutics. https://doi.org/10.1038/clpt.2010.65
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.